Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background.: An infectious disease (ID) consultation (consult) is often obtained to treat patients with cryptococcosis due to the complex nature of the disease, but has never been demonstrated to impact outcomes. Methods.: We assembled a retrospective cohort of 147 consecutive cases of cryptococcosis in patients without human immunodeficiency virus. Patients who were diagnosed <24 hours prior to death were excluded. Survival analysis was performed with Cox regression with survival censored past 90 days. Results.: The patients with an ID consult had a higher fungal burden but a lower 90-day mortality compared with patients without ID involvement (27% vs 45%; P < .001), with an adjusted hazard ratio of not receiving an ID consult of 4.2 (95% confidence interval, 2.2–7.6). The ID consult group was more likely to receive an indicated lumbar puncture (86% vs 32%; P < .001), and more likely to be treated with amphotericin B (AmB) (87% vs 24%; P < .001) and flucytosine (5-FC) (57% vs 16%; P < .001) when indicated. The duration of therapy with AmB (14 vs 11 days; P = .05) and 5-FC (7.5 days vs 1 day; P < .001) was longer in the ID consult group. Conclusions.: Patients who received an ID consult were significantly less likely to die in the 90 days following diagnosis. Patients seen by ID physicians were more likely to be managed according to evidence-based practice established by randomized controlled trials and published in Infectious Diseases Society of America guidelines. These data suggest that an ID consult should be an integral part of clinical care of patients with cryptococcosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationJarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit794 · Cited by 367 · cited 4×
“Elevations of both serum cryptococcal antigen [12, 13, 28], and another marker of cryptococcal burden, the quantitative cryptococcal culture [23], have been associated with higher 2-week mortality.”
BackgroundInfluentialEnd-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis
Spec, A., Raval, K., & Powderly, W. G. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv197 · Cited by 65 · cited 4×
“Sites of infection and associated predisposing factors were defined as previously described [2].”
BackgroundResultInfluentialSelf-citation
Cited by
Burnham, J. P., Olsen, M. A., Stwalley, D., Kwon, J. H., Babcock, H. M., & Kollef, M. H. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy026 · Cited by 90
Self-citationFungal dissemination is limited by liver macrophage filtration of the blood
Sun, D., Sun, P., Li, H., Zhang, M., Liu, G., Strickland, A. B., Chen, Y., Fu, Y., Xu, J., Yosri, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12381-5 · Cited by 83
A titanic drug resistance threat in Cryptococcus neoformans
Zafar, H., Altamirano, S., Ballou, E. R., & Nielsen, K. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.11.001 · Cited by 76
Metadata
- Authors
- Spec, A., Olsen, M. A., Raval, K., & Powderly, W. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-09
- Volume
- 64
- Issue
- 5
- Pages
- 558-564
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2560337566
- Cited by
- 53
- References
- 3
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.